Mood Disorder

Preexisting mental disorders, particularly psychotic and mood disorders, as well as exposure to antipsychotics and anxiolytics, increased risk for COVID-19-related mortality.

Several factors increased risk for stimulant treatment discontinuation and switch to nonstimulants among people with ADHD, according to study results published in American Journal of Psychiatry.

Pediatric patients with headache experienced increased headache frequency, poorer anxiety and mood, less physical activity and more screen time during the COVID-19 pandemic, despite reported improvements in hydration, sleep and diet.

Hospitalized individuals who had mood disorder history were at increased risk for greater COVID-19 morbidity and mortality, according to results of a retrospective cohort study published in American Journal of Psychiatry.

Separation anxiety may significantly predict suicidal thoughts among patients with mood and anxiety disorders, according to study results published in Journal of Clinical Psychiatry.

Adults aged at least 65 years with type 2 diabetes, obstructive sleep apnea and insomnia experienced less diabetes-related stress and better mood and functional outcomes compared with younger peers, according to study data.

Healio Psychiatry has compiled a list of its five most-viewed stories in January.

Schizophrenia spectrum disorder diagnosis appeared to be a significant risk factor for mortality among individuals with COVID-19, according to results of a retrospective cohort study published in JAMA Psychiatry.

Researchers have developed a novel test to predict mood disorders based on levels of a protein found in the brain, according to study results published in Journal of Psychiatric Research.

Mood disorders appeared linked to elevated and early rates of disability services, according to results of a cohort study published in JAMA Network Open.